chr16-85902657-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002163.4(IRF8):c.-1-358C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 330,642 control chromosomes in the GnomAD database, including 4,579 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1883 hom., cov: 32)
Exomes 𝑓: 0.16 ( 2696 hom. )
Consequence
IRF8
NM_002163.4 intron
NM_002163.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.348
Publications
8 publications found
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
IRF8 Gene-Disease associations (from GenCC):
- Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiencyInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Illumina
- immunodeficiency 32BInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IRF8 | NM_002163.4 | c.-1-358C>T | intron_variant | Intron 1 of 8 | ENST00000268638.10 | NP_002154.1 | ||
| IRF8 | XM_047434052.1 | c.-204C>T | 5_prime_UTR_variant | Exon 2 of 10 | XP_047290008.1 | |||
| IRF8 | NM_001363907.1 | c.-204C>T | upstream_gene_variant | NP_001350836.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IRF8 | ENST00000268638.10 | c.-1-358C>T | intron_variant | Intron 1 of 8 | 1 | NM_002163.4 | ENSP00000268638.4 |
Frequencies
GnomAD3 genomes AF: 0.143 AC: 21736AN: 152142Hom.: 1883 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21736
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.164 AC: 29217AN: 178382Hom.: 2696 Cov.: 0 AF XY: 0.159 AC XY: 15189AN XY: 95520 show subpopulations
GnomAD4 exome
AF:
AC:
29217
AN:
178382
Hom.:
Cov.:
0
AF XY:
AC XY:
15189
AN XY:
95520
show subpopulations
African (AFR)
AF:
AC:
241
AN:
5412
American (AMR)
AF:
AC:
1656
AN:
9374
Ashkenazi Jewish (ASJ)
AF:
AC:
715
AN:
4358
East Asian (EAS)
AF:
AC:
2123
AN:
8372
South Asian (SAS)
AF:
AC:
3780
AN:
31120
European-Finnish (FIN)
AF:
AC:
1206
AN:
7942
Middle Eastern (MID)
AF:
AC:
156
AN:
638
European-Non Finnish (NFE)
AF:
AC:
17705
AN:
102116
Other (OTH)
AF:
AC:
1635
AN:
9050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1134
2269
3403
4538
5672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.143 AC: 21731AN: 152260Hom.: 1883 Cov.: 32 AF XY: 0.143 AC XY: 10627AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
21731
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
10627
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
1837
AN:
41568
American (AMR)
AF:
AC:
2685
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
629
AN:
3468
East Asian (EAS)
AF:
AC:
1315
AN:
5180
South Asian (SAS)
AF:
AC:
686
AN:
4826
European-Finnish (FIN)
AF:
AC:
1846
AN:
10608
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12255
AN:
68010
Other (OTH)
AF:
AC:
355
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
951
1902
2852
3803
4754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
688
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.